FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076075328> ?p ?o ?g. }

• W2076075328 endingPage "309" @default.
• W2076075328 startingPage "301" @default.
• W2076075328 abstract "Mitoxantrone (MIT, 12 mg/m2, i.v. 5 days) and intermediate-dose cytosine arabinoside (IDAC 1 g/m2/12 h, i.v. 3 days) was given to 43 patients with poor-risk acute leukemias (AL). Moderate or severe toxicity was infrequent. The proportion of complete remissions (CR) in the main patient categories was as follows: 15/18 (85 per cent) in acute myeloid leukemia (AML) in the first relapse, 2/6 in ALL in the first relapse, 0/2 in AML in relapse after bone marrow transplantation (BMT), 2/7 in AML refractory to first-line treatment (REFAL), and 1/6 in postmyelodysplastic (PMD-AL) plus secondary AL (S-AL). The mortality rate during induction was 23 per cent. Median duration of CR was 24 weeks. The multivariate prognostic factor analysis on CR obtention showed that data concerning treatment for the first relapse and platelet count higher than the median of the series were favourable. On the contrary, PMD-AL, S-AL and REF-AL were unfavourable situations. A percentage of marrow erythroblasts superior to the median was a favourable prognostic factor for survival. Finally, the duration of CR after MIT-IDAC was directly related to the duration of previous CR. In conclusion, MIT-IDAC was highly effective to attain CR in AML in the first relapse. However, due to the poor long-term results in these patients, additional measures are recommended after CR." @default.
• W2076075328 created "2016-06-24" @default.
• W2076075328 creator A5012535366 @default.
• W2076075328 creator A5025894116 @default.
• W2076075328 creator A5029260153 @default.
• W2076075328 creator A5054008156 @default.
• W2076075328 creator A5068295181 @default.
• W2076075328 creator A5076935487 @default.
• W2076075328 creator A5086556836 @default.
• W2076075328 creator A5090853519 @default.
• W2076075328 date "1992-11-01" @default.
• W2076075328 modified "2023-10-18" @default.
• W2076075328 title "Mitoxantrone and intermediate-dose cytosine arabinoside for poor-risk acute leukemias: Response to treatment and factors influencing outcome" @default.
• W2076075328 cites W1591796471 @default.
• W2076075328 cites W1709114039 @default.
• W2076075328 cites W1804439365 @default.
• W2076075328 cites W1809290747 @default.
• W2076075328 cites W1967554235 @default.
• W2076075328 cites W2029007438 @default.
• W2076075328 cites W2030146969 @default.
• W2076075328 cites W2038252730 @default.
• W2076075328 cites W2040367419 @default.
• W2076075328 cites W2044310091 @default.
• W2076075328 cites W2068121922 @default.
• W2076075328 cites W2075761692 @default.
• W2076075328 cites W2098371527 @default.
• W2076075328 cites W2102086131 @default.
• W2076075328 cites W2130092928 @default.
• W2076075328 cites W2211072972 @default.
• W2076075328 cites W2271039096 @default.
• W2076075328 cites W2309356125 @default.
• W2076075328 cites W24057889 @default.
• W2076075328 cites W2416628098 @default.
• W2076075328 cites W4230626149 @default.
• W2076075328 cites W4236309725 @default.
• W2076075328 cites W4293241248 @default.
• W2076075328 doi "https://doi.org/10.1002/hon.2900100603" @default.
• W2076075328 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1296931" @default.
• W2076075328 hasPublicationYear "1992" @default.
• W2076075328 type Work @default.
• W2076075328 sameAs 2076075328 @default.
• W2076075328 citedByCount "8" @default.
• W2076075328 countsByYear W20760753282018 @default.
• W2076075328 crossrefType "journal-article" @default.
• W2076075328 hasAuthorship W2076075328A5012535366 @default.
• W2076075328 hasAuthorship W2076075328A5025894116 @default.
• W2076075328 hasAuthorship W2076075328A5029260153 @default.
• W2076075328 hasAuthorship W2076075328A5054008156 @default.
• W2076075328 hasAuthorship W2076075328A5068295181 @default.
• W2076075328 hasAuthorship W2076075328A5076935487 @default.
• W2076075328 hasAuthorship W2076075328A5086556836 @default.
• W2076075328 hasAuthorship W2076075328A5090853519 @default.
• W2076075328 hasConcept C126322002 @default.
• W2076075328 hasConcept C142424586 @default.
• W2076075328 hasConcept C143998085 @default.
• W2076075328 hasConcept C2776023528 @default.
• W2076075328 hasConcept C2776694085 @default.
• W2076075328 hasConcept C2778041864 @default.
• W2076075328 hasConcept C2778729363 @default.
• W2076075328 hasConcept C2780007613 @default.
• W2076075328 hasConcept C2780923524 @default.
• W2076075328 hasConcept C29730261 @default.
• W2076075328 hasConcept C38180746 @default.
• W2076075328 hasConcept C54355233 @default.
• W2076075328 hasConcept C552990157 @default.
• W2076075328 hasConcept C71924100 @default.
• W2076075328 hasConcept C86803240 @default.
• W2076075328 hasConcept C87355193 @default.
• W2076075328 hasConcept C90924648 @default.
• W2076075328 hasConceptScore W2076075328C126322002 @default.
• W2076075328 hasConceptScore W2076075328C142424586 @default.
• W2076075328 hasConceptScore W2076075328C143998085 @default.
• W2076075328 hasConceptScore W2076075328C2776023528 @default.
• W2076075328 hasConceptScore W2076075328C2776694085 @default.
• W2076075328 hasConceptScore W2076075328C2778041864 @default.
• W2076075328 hasConceptScore W2076075328C2778729363 @default.
• W2076075328 hasConceptScore W2076075328C2780007613 @default.
• W2076075328 hasConceptScore W2076075328C2780923524 @default.
• W2076075328 hasConceptScore W2076075328C29730261 @default.
• W2076075328 hasConceptScore W2076075328C38180746 @default.
• W2076075328 hasConceptScore W2076075328C54355233 @default.
• W2076075328 hasConceptScore W2076075328C552990157 @default.
• W2076075328 hasConceptScore W2076075328C71924100 @default.
• W2076075328 hasConceptScore W2076075328C86803240 @default.
• W2076075328 hasConceptScore W2076075328C87355193 @default.
• W2076075328 hasConceptScore W2076075328C90924648 @default.
• W2076075328 hasIssue "6" @default.
• W2076075328 hasLocation W20760753281 @default.
• W2076075328 hasLocation W20760753282 @default.
• W2076075328 hasOpenAccess W2076075328 @default.
• W2076075328 hasPrimaryLocation W20760753281 @default.
• W2076075328 hasRelatedWork W129450057 @default.
• W2076075328 hasRelatedWork W2053906221 @default.
• W2076075328 hasRelatedWork W2056183502 @default.
• W2076075328 hasRelatedWork W2062064479 @default.
• W2076075328 hasRelatedWork W2070616033 @default.
• W2076075328 hasRelatedWork W2188337530 @default.
• W2076075328 hasRelatedWork W2349679547 @default.

• next